肺癌筛查年度依从性的决定因素:基于理赔数据的回顾性分析
本研究利用科罗拉多全 payer 理赔数据库,纳入 9056 例接受低剂量 CT 肺癌筛查者,以索引后 10–18 个月再次筛查 CT 理赔定义为依从。Cox 回归显示 55–59、60–64、75–79 岁、农村居住、 Medicare FFS 和 Medicaid 与较低依从性相关,门诊使用与合并症的交互显著。
要点
- 年龄 55–64 岁及 75–79 岁、农村居民、 Medicare FFS 或 Medicaid 参保者年度筛查依从性较低。
- 门诊就诊频率增加与依从性提高相关,无合并症者中该关联最明显。
- 识别低依从人群有助于针对性干预,以最大化肺癌筛查获益。
英文原文(摘要)· 点击展开
OBJECTIVE: Lung cancer screening (LCS) efficacy is highly dependent on adherence to annual screening, but little is known about real-world adherence determinants. We used insurance claims data to examine associations between LCS annual adherence and demographic, comorbidity, health care usage, and geographic factors.
MATERIALS AND METHODS: Insurance claims data for all individuals with an LCS low-dose CT scan were obtained from the Colorado All Payer Claims Dataset. Adherence was defined as a second claim for a screening CT 10 to 18 months after the index claim. Cox proportional hazards regression was used to define the relationship between annual adherence and age, gender, insurance type, residence location, outpatient health care usage, and comorbidity burden.
RESULTS: After exclusions, the final data set consisted of 9,056 records with 3,072 adherent, 3,570 nonadherent, and 2,414 censored (unclassifiable) individuals. Less adherence was associated with ages 55 to 59 (hazard ratio [HR] = 0.80, 99% confidence interval [CI] = 0.67-0.94), 60 to 64 (HR = 0.83, 99% CI = 0.71-0.97), and 75 to 79 (HR = 0.79, 99% CI = 0.65-0.97); rural residence (HR = 0.56, 99% CI = 0.43-0.73); Medicare fee-for-service (HR = 0.45, 99% CI = 0.39-0.51), and Medicaid (HR = 0.50, 99% CI = 0.40-0.62). A significant interaction between outpatient health care usage and comorbidity was also observed. Increased outpatient usage was associated with increased adherence and was most pronounced for individuals without comorbidities.
CONCLUSIONS: This population-based description of LCS adherence determinants provides insight into populations that might benefit from specific interventions targeted toward improving adherence and maximizing LCS benefit. Quantifying population-based adherence rates and understanding factors associated with annual adherence are critical to improving screening adherence and reducing lung cancer death.
引用
- Hirsch EA, Barón AE, Risendal B, et al. Determinants Associated With Longitudinal Adherence to Annual Lung Cancer Screening: A Retrospective Analysis of Claims Data. J Am Coll Radiol. 2021. PMID: 33798496. doi:10.1016/j.jacr.2021.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。